ID

34330

Description

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4; ODM derived from: https://clinicaltrials.gov/show/NCT01884402

Lien

https://clinicaltrials.gov/show/NCT01884402

Mots-clés

  1. 16/01/2019 16/01/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

16 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hepatitis C, Chronic NCT01884402

Eligibility Hepatitis C, Chronic NCT01884402

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with > 18 years old.
Description

ID.1

Type de données

boolean

patients diagnosed with chronic hepatitis c in the presence of hcv rna in plasma that meet criteria for initiating antiviral therapy in routine clinical practice conditions.
Description

ID.2

Type de données

boolean

patients genotype 1 and 4.
Description

ID.3

Type de données

boolean

patients with the results of all the factors evaluable at the time of inclusion.
Description

ID.4

Type de données

boolean

patients who have accepted their participation in the study through informed consent.
Description

ID.5

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients previously treated with interferon (ifn) and ribavirin (rbv).
Description

ID.6

Type de données

boolean

patients with genotype 2, 3, 5 and 6.
Description

ID.7

Type de données

boolean

patients with co-infection with hepatitis b.
Description

ID.8

Type de données

boolean

patients with other liver diseases.
Description

ID.9

Type de données

boolean

patients with any contraindications to the drugs used in the treatment of hepatitis
Description

ID.10

Type de données

boolean

Similar models

Eligibility Hepatitis C, Chronic NCT01884402

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with > 18 years old.
boolean
ID.2
Item
patients diagnosed with chronic hepatitis c in the presence of hcv rna in plasma that meet criteria for initiating antiviral therapy in routine clinical practice conditions.
boolean
ID.3
Item
patients genotype 1 and 4.
boolean
ID.4
Item
patients with the results of all the factors evaluable at the time of inclusion.
boolean
ID.5
Item
patients who have accepted their participation in the study through informed consent.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
patients previously treated with interferon (ifn) and ribavirin (rbv).
boolean
ID.7
Item
patients with genotype 2, 3, 5 and 6.
boolean
ID.8
Item
patients with co-infection with hepatitis b.
boolean
ID.9
Item
patients with other liver diseases.
boolean
ID.10
Item
patients with any contraindications to the drugs used in the treatment of hepatitis
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial